Cancer Services

901. Deputy Claire Kerrane asked the Minister for Health in relation to breast screening, to outline the circumstances in which MRI or targeted ultrasound are available instead of mammogram; if such alternatives may be made more widely available; and if she will make a statement on the matter. [55424/25]

357. Deputy John McGuinness asked the Minister for Health the number of mammograms provided at University Hospital Waterford in each of the past 12-months; the average waiting time for mammograms to be read and for the patients to be informed of the outcome; the number of follow-ups required; the average waiting time for individuals to be informed; the waiting time for treatments thereafter; and i…

312. Deputy Claire Kerrane asked the Minister for Health if the HSE will approve treatment for a constituent (details supplied); and if she will make a statement on the matter. [54026/25]

641. Deputy Michael Cahill asked the Minister for Health to implement the necessary measures to improve cancer services across the country and save lives (details supplied); and if she will make a statement on the matter. [53395/25]

77. Deputy Marie Sherlock asked the Minister for Health to account for the dramatic drop over the past eight years in breast cancer patients with an identified B5 or C5 receiving surgical intervention within the 20-working day target - with surgery identified as the first treatment; and if she will make a statement on the matter. [52489/25]

79. Deputy Pádraig Rice asked the Minister for Health the steps she is taking to address the serious deficits in staffing and equipment in public radiation therapy services; if she will instruct the HSE to offer all radiation therapy graduates employment; and if she will make a statement on the matter. [52861/25]

88. Deputy Paul McAuliffe asked the Minister for Health the immediate plans to increase the current resources at the Mater hospital to reduce the waiting time for those seeking an oncology appointment; and if she will make a statement on the matter. [52563/25]

110. Deputy Paul McAuliffe asked the Minister for Health if there are plans, within the next year, to increase resources nationwide to address the wait times for those seeking an oncology appointment; and if she will make a statement on the matter. [52564/25]

418. Deputy Erin McGreehan asked the Minister for Health if she is aware of the case of person (details supplied) diagnosed with B-cell acute lymphoblastic leukaemia, who is currently ineligible for CAR T-cell therapy due to the treatment being licensed in Ireland only for individuals under the age of 26; if she will clarify the basis for this age restriction; the reason Ireland differs from other…

449. Deputy Donna McGettigan asked the Minister for Health the current staffing complement of the National Cervical Screening Laboratory, by discipline and grade, in tabular form; the required staffing necessary to fully repatriate screening services; and if she will make a statement on the matter. [52803/25]

454. Deputy Ken O'Flynn asked the Minister for Health the average time taken by the National Centre for Pharmacoeconomics and her Department to complete health technology assessments and reimbursement decisions on oncology drugs in the past three years; and whether target timelines exist to expedite access for public patients. [52825/25]

455. Deputy Ken O'Flynn asked the Minister for Health if her Department has entered into outcomes-based or risk-sharing agreements with pharmaceutical companies in respect of new cancer drugs; and if so, to provide details of the drugs concerned, the duration of the agreements, and the outcomes being measured. [52826/25]

456. Deputy Ken O'Flynn asked the Minister for Health the projected level of additional annual funding required over the next five years to ensure that all newly approved cancer drugs are made available to public patients in a timely manner; and whether ring-fenced oncology funding is being considered within her Department. [52827/25]

457. Deputy Ken O'Flynn asked the Minister for Health whether her Department has carried out any equality or impact assessment on disparities in access to oncology drugs between public and private patients; and if so, to publish those findings. [52828/25]

458. Deputy Ken O'Flynn asked the Minister for Health to provide comparative data on the time from European Medicines Agency approval to reimbursement for new oncology medicines in Ireland versus other EU member states; and to indicate whether Ireland is above or below the EU average. [52829/25]

459. Deputy Ken O'Flynn asked the Minister for Health if she will publish in full the rationale, minutes, and assessments underpinning reimbursement decisions on oncology drugs since 2020; and if not, the reason for the continued confidentiality. [52830/25]

460. Deputy Ken O'Flynn asked the Minister for Health whether a national registry of oncology patients treated with newer cancer therapies is maintained; and if so, to outline how this real-world data informs reimbursement and future access decisions. [52831/25]

461. Deputy Ken O'Flynn asked the Minister for Health the steps being taken to accelerate the availability of oncology generics and biosimilars to reduce cost barriers for the public health system; and whether legislative or regulatory reform is being considered in this regard. [52832/25]

462. Deputy Donna McGettigan asked the Minister for Health the number of patients precluded from accessing CAR T-cell treatment due to the current age restriction on the treatment, per county, in tabular form; and if she will make a statement on the matter. [52849/25]

197. Deputy Pádraig Rice asked the Minister for Health if she has received a business case from a group (details supplied); the status of her Department’s consideration of same; if she has engaged with the group concerned since receiving its business case; and if she will make a statement on the matter. [52393/25]

238. Deputy David Cullinane asked the Minister for Health the number and percentage of symptomatic breast cancer attendances in 2024 and to date in 2025 whose referrals were triaged as urgent and which did not adhere to the national standard of 2 weeks for urgent referrals. [52607/25]

239. Deputy David Cullinane asked the Minister for Health the number and percentage of lung cancer rapid access clinic attendances in 2024 and to date in 2025 who were offered an appointment within ten working days. [52608/25]

240. Deputy David Cullinane asked the Minister for Health the number and percentage of prostate cancer rapid access clinic attendances in 2024 and to date in 2025 who were offered an appointment within 20 working days. [52609/25]

241. Deputy David Cullinane asked the Minister for Health the number and percentage of patients undergoing radical radiotherapy treatment who commenced treatment within 15 working days of being deemed ready to treat, by location, for the period 2024 to date in 2025, in tabular form. [52610/25]

242. Deputy David Cullinane asked the Minister for Health the number and percentage of new patients attending rapid access breast, lung and prostate clinics within recommended timeframes for 2024 and to date in 2025, in tabular form. [52611/25]